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Re: Analysis of Dioxin Cancer
Threshold
Mackie et al. (2003) present an exploratory
Monte Carlo meta-regression of selected
cohort mortality and exposure data for three
dioxin-exposed cohorts [National Institute
for Occupational Safety and Health
(NIOSH), Ranch Hand, and Seveso] as a
critique of our earlier publication of a simi-
lar analysis (Kirman et al. 2000). Although
we appreciate that our preliminary examina-
tions of the cohort mortality dose–response
data have been followed by more detailed
analyses of these data (e.g., Crump et al.
2003), we disagree with a number of
Mackie et al.’s procedures, assertions, and
conclusions. 
Mackie et al. (2003) assert that no
weighting of the individual cohort data
points is necessary and that a linear regres-
sion of the unweighted dose–response data
is appropriate. We disagree. The data used
in the regression analysis include observa-
tions obtained for groups ranging from 19
individuals (Ranch Hand Group R4) to
15,000 individuals (Seveso Zone R females).
In an unweighted regression, dose–response
information from these two groups is
weighted equally, which is clearly inappro-
priate. Weighting by sample size, while rela-
tively simplistic, eliminates the sensitivity of
the regression results to either study size or
data-grouping decisions of the study
authors. For example, the unweighted fits by
Mackie et al. would have been quite differ-
ent if the results for women in Seveso Zone
R had been reported for 789 groups of 19
individuals rather than one group of 15,000.
The data are probably best analyzed using a
Poisson regression. Estimators produced by
maximizing the likelihood function in a
Poisson regression are generally preferred
over those produced by least squares based
on their statistical properties, and the data
are automatically weighted based on the
expected number of deaths (highly corre-
lated with population size). The results of a
Poisson regression would be expected to be
nearly identical to those obtained using a
population-weighted least-squares regression
(ongoing work confirms this). 
The broad conclusion of Mackie et al.
(2003) that the data provide no evidence of
a threshold is based on analysis of only
three of the five cohorts with available
dose–response data. Further, the data used
in their analysis do not reflect the most cur-
rent mortality information available for two
of the three included cohorts [NIOSH
cohort, updated by Steenland et al. (2001);
Seveso cohort, updated by Bertazzi et al.
(2001)]. Mackie et al.’s conclusion of no
evidence of a threshold seems unreasonable
on the basis of this incomplete analysis.
Crump et al. (2003) noted that the
dose–response data from the manufacturing
cohorts do not show any positive trend
until groups with estimated doses well
above current background exposures are
included. Data from the Seveso cohort are
consistent with this observation.
Finally, data from the occupational
cohorts indicate an underlying elevation in
cancer mortality independent of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) expo-
sure [standard mortality ratio between 115
and 120 at zero dioxin exposure (Crump
et al. 2003; Starr 2001)], consistent with
possible confounding by exposure to other
chemicals in the workplace, elevated smok-
ing rates, or other factors. In contrast, the
data from the Seveso and Ranch Hand pop-
ulations, with more appropriate control
populations, do not show this underlying
elevation at zero exposure. Combining these
two groups of populations into a single
meta-regression may result in spurious
effects on the apparent shape of the
dose–response curve unless this elevation is
accounted for.
In this respect, we agree with Mackie et
al. (2003) that the epidemiologic data must
be analyzed carefully using appropriate statis-
tical and commonsense approaches, and with
an awareness of the strengths and weaknesses
of the underlying data. However, we think
additional work remains to be done to fully
appreciate the implications of the available
epidemiologic data for the cancer dose–
response of TCDD in humans.
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Editor’s note: In accordance with journal policy,
Mackie et al. were asked whether they wanted to
respond to this letter. They chose not to do so. 
Exposure to Lead and an Old
Way of Counting
We read with great interest the commentary
by Jacobs et al. (2003) on the high cost of
improper removal of lead-based paint and
would like to address two issues, both
related to the monitoring of lead-based
paint. The first is the importance of animal
sentinels and the second is the potential of
the capture–recapture method (CRM) (also
called the mark–recapture method) for
determining the number of homes with
lead-based paint. 
The commentary by Jacobs et al. (2003)
addresses issues and concerns related to cost
when lead-based paint removal is per-
formed improperly. The case study refer-
enced by Jacobs et al. first arose from the
discovery that the family pet, a dog, died
from apparent lead poisoning. Discovery of
lead poisoning through a family pet has
been previously reported (Dowsett and
Shannon 1994), and some have suggested
that pets are good sentinels for poisoning of
children (Berny et al. 1995). 
A similar event took place in western
Pennsylvania in the 1980s (Lange JH.
Unpublished data): a homeowner reported
that the family’s dog was exhibiting unusual
behavior. A veterinarian tested the dog and
determined that it had lead poisoning. A
water tower on property bordering the resi-
dence was being sandblasted and repainted,
and sand had been distributed throughout
the yard, with some inside the residence.
The contractor had put a tarp barrier over
the chain-linked fence as the only control
measure to prevent spread of sand, dust,
and lead-based paint. After the finding of
lead poisoning in the dog, the single resi-
dent in this home was tested for blood lead;
the resident also had lead poisoning (blood
lead level by venous draw > 25 µg/dL). 
Most home and building owners are not
aware of the hazards of lead-based paint nor
its presence (Lange et al. 1998). Thus, it is
common that renovation, repair, and/or
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of lead-control or lead-safe practices (Lange
et al. 1998; Lange and Thomulka 2000),
with most never discovering the hazard or
even being concerned (Lange et al. 1998).
Sentinel events identify potential areas
of concern; however, they do not determine
the magnitude of the problem. One of the
difficulties in understanding the lead haz-
ards is their magnitude (Jacobs et al. 2002).
There is currently no good estimate for the
number of homes having lead-based paint
and the incidence and prevalence of lead-
poisoned children and adults in most local
areas. Accurate estimates of these parame-
ters would better identify the extent of the
problem in local communities. Why these
estimates are not known is a result of the
difficulty in collecting accurate data.
However, a nontraditional environmental
health method can be used for providing
these estimates: the CRM (LaPorte et al.
1992; McCarty et al. 1993). The CRM has
been used for decades by population ecolo-
gists and others who count wildlife (LaPorte
et al. 1992). This method will allow sam-
pling of the population, including homes
with lead-based paint, to determine the inci-
dence and prevalence at a fraction of tradi-
tional costs. To better identify the problems
of lead, it is necessary to employ new and
innovative methods such as the CRM. 
With the CRM, population ecologists
take a sample of fish, for example, from
Lake Erie, and count them, tag them, and
return them to the lake; then on the next
day, they once again capture a sample of
fish and identify the numbers of fish that
were caught. Using a simple formula, such
as the one presented, it is possible to esti-
mate numbers of fish in the lake.
When estimating numbers of people
with lead poisoning, we can use multiple
sources of case ascertainment, including hos-
pitals, laboratories, and schools. Each list
represents a capture, and the duplicates on
the lists represent the recaptures. We can use
the same approach for estimating the num-
ber of houses with lead-based paint (i.e., the
number of houses that might be contami-
nated). To do this, it would be necessary to
obtain multiple incomplete listings of
houses with lead-based paint from local
agencies, the houses where lead poisoned
children lived, surveys, and so on. The
incomplete lists represent the captures, and
the houses that appear on duplicate lists
would represent the recaptures. Using a sim-
ple formula, we can obtain an estimate that
controls for ascertainment.
where N is the estimate of number, M is the
number marked in the first sample, n is the
number collected in the second sample, and
m is the number of those marked in the sec-
ond sample that were collected.
Because some of the houses could be
false positives, a random sample of the
houses could be tested. Then the estimated
count could be adjusted to ensure accuracy
of identification on the lists.
The animal reports demonstrate the
importance of sentinels for detecting lead
poisoning in people. The use of the CRM
illustrates a more effective method for
determining the number of people who
experience lead poisoning and the number
of homes that contain lead-based paint.
Such information will allow a more accu-
rate assessment of the problem and the
financial resources needed for control. 
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Carbon Monoxide Exposure
and Carboxyhemoglobin
Given recent survey data showing that
physicians ask their patients about carbon
monoxide less frequently than any other
common environmental health hazard
(Kilpatrick et al. 2002), I welcome your
effort to increase awareness of CO by pub-
lishing the case report of Devine et al. (2002)
documenting “MRI and Neuropsychological
Correlates of Carbon Monoxide Exposure.”
But why did they include a table purporting
to specify “Human responses and approxi-
mate ambient CO air levels at various car-
boxyhemoglobin concentrations” (Table 2;
Devine et al. 2002)? 
Devine et al. (2002) reported being
unable to obtain any CO exposure data and
did not even mention their patient’s car-
boxyhemoglobin (HbCO) level, which they
apparently saw no need to measure or even
report. In fact, Devine et al. gave several
reasons for not relying on HbCO, includ-
ing (quoting Myers et al. 1998) that it is “of
little value in diagnosing either acute or
chronic CO poisoning.” 
Their Table 2 (Devine et al. 2002) is
misleading because it does not specify the
duration of CO exposure, air temperature,
altitude, the initial HbCO level of those
exposed, the level of physical exertion,
smoking status, blood alcohol level, breath-
ing rate, age, or any of the many other vari-
ables known to significantly influence the
variety and severity of CO symptoms at any
HbCO level. 
Most misleading is that the table suggests
that no symptoms of any kind—aside from
angina in heart patients upon exertion—
should be expected under 10% HbCO.
EHP is just one of several journals that have
recently published large studies of human
CO exposure documenting that increases of
just 1–2 ppm in average outdoor CO lev-
els—well below those associated with any
increase in HbCO—are more significantly
associated with increasing asthma preva-
lence (Guo et al. 1999) and asthma attacks
(Yu et al. 2000) than any other atmospheric
pollutant including ozone and particulates. 
Moreover, although Devine et al. (2002)
referenced their Table 2 to “data from
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CorrespondenceO’Donoghue” (O’Dohoghue 1985), from
which it was indeed copied, O’Donoghue’s
version does not cite any actual data but
merely four other sources (Ginsberg 1980;
Stewart 1975, 1976; Stewart et al. 1970).
Although three of these contain similar
HbCO tables, they also do not cite any rele-
vant data, just other published sources. 
I had to check 14 such references before
I found what appears to be the original
table—itself unreferenced—in a typewritten
“Report of Investigations” published by the
U.S. Bureau of Mines in 1923 (Sayers and
Yant 1923), apparently without any external
peer review. The table (Sayers and Yant
1923) was qualified with the phrase “in gen-
eral” and was clearly not based on any actual
human data or study. Given that the version
published by Devine et al. (2002) is thus
without any credible foundation, misleading
in its content, and irrelevant to their
reported case, I urge them to retract it from
their otherwise excellent paper. 
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Carbon Monoxide Exposure
and Carboxyhemoglobin:
Response from White et al.
In his letter, Donnay objects to the inclusion
in our paper (Devine et al. 2002) of a table
(Table 2) describing signs and symptoms
associated with several levels of carbon
monoxide exposure and carboxyhemoglobin
(HbCO) blood saturation. This table pre-
sents a historical perspective on the known
physical effects of CO. The information con-
tained in it is very different from that sum-
marized in the case report, which details
subtle effects of chronic low-level CO expo-
sure on behavioral and cognitive function.
Our Table 2, which was not included in the
initial submission of this paper to EHP, was
added at the request of reviewers. It was felt
that such a table would provide a compari-
son point regarding historical, longstanding
beliefs about CO effects. In the case report,
this knowledge is compared to more recent
research and clinical reports of CO effects
and their relationship to HbCO. 
We do not see a compelling reason for
retracting the table from the paper, espe-
cially given the context of our presentation
on subtle effects of CO.
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